This website uses cookies to enhance the user experience.
J

J E GREVE AS931 001 612

Real Estate
Limited company
Vestre Strømkaien 7 5008 BERGEN, Norge

J E GREVE AS

Keywords

real estatetenementshomesbuildingsexhibition hallswarehousesshopping centresland propertiessubdivision

Organization

Chairman of the board
Years since formation
29 years
since Feb 19, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
536
2 share classes
Total number of shareholders
5
1 company, 4 persons

Financials

Annual total result 2023
172,157
NOK
Total equity 2023
18,490,661
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Chairman
21.46 %
indirectly
Board Member
35.63 %
directly
Board Member
21.46 %
directly
Board Member
21.46 %
directly

Others

NameRoleShares
D
DELOITTE AS
Auditor-
A
AZETS INSIGHT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
35.63 %
directly
Chairman
21.46 %
indirectly
Board Member
21.46 %
directly
Board Member
21.46 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Class B shares
163
30.41 %
P
POSITANO AS
A-shares
115
21.46 %
A-shares
115
21.46 %
A-shares
115
21.46 %
A-shares
28
5.22 %

Shares owned by the J E GREVE AS

NameShare classNumber of sharesShare
C
CHEM ANCHOR INVEST VII AS
Ordinary shares
193
6.89 %
C
CHEM ANCHOR INVEST VIII AS
Ordinary shares
82
3.9 %
C
CHEM ANCHOR INVEST XI AS
Ordinary shares
145
3.45 %
NO0010649148
192
0.53 %
S
SARSIA SEED AS
Ordinary shares
2,569
0.51 %
A
AS KISTEFOS TRÆSLIBERI
Ordinary shares
16
0.18 %
A
AKSJEREDERIET ATLANTIC AS
Ordinary shares
2
0.14 %
A
AS CALORIC
Ordinary shares
1
0.09 %
D
DEEPX HEALTH AS
NO0010159700
52,145
0.08 %
N
NORDIC TECHNOLOGY GROUP AS
NO0011018434
42,098
0.06 %
G
GC RIEBER EIENDOM AS
NO0011202798
2,126
0.06 %
N
NORDA ASA
NO0010285190
2,058
0.04 %
E
ELLIPTIC LABORATORIES ASA
NO0010722283
40,000
0.04 %
S
SPAREBANKEN VEST
NO0006000900
19,785
0.02 %
E
EPSIS AS
NO0010322514
1,334
0.02 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
75,000
0.02 %
B
BERGENBIO ASA
NO0010650013
379,566
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
172,157
-650,052
3,681,175
Total assets
18,520,661
19,848,504
20,759,273
Total liabilities
30,000
3,030,000
290,717
Total equity
18,490,661
16,818,504
20,468,556

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
248,074
232,304
245,711
Operating result
-248,074
-232,304
-245,711
Financial income/costs
420,231
-423,865
3,933,002
Profit before tax
172,157
-656,169
3,687,292
Total tax & extraordinary income/cost
0
-6,117
6,117
Annual Total Result
172,157
-650,052
3,681,175

Balance overview

Year202320222021
Total fixed assets
0
17,376,983
17,121,313
Total current assets
18,520,661
2,471,522
3,637,960
Total assets
18,520,661
19,848,504
20,759,273
Short term debt
30,000
3,030,000
284,600
Long term debt
0
0
6,117
Total liabilities
30,000
3,030,000
290,717
Contributed capital
9,162,680
9,162,680
9,162,680
Retained earnings
9,327,981
7,655,824
11,305,876
Total equity
18,490,661
16,818,504
20,468,556
Total equity and liabilities
18,520,661
19,848,504
20,759,273

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
L
Main industrial area
Real estate activities
68
Activity
Real estate activities
68.1
Main industrial group
Buying and selling of own real estate
68.10
Industrial group
Buying and selling of own real estate
68.100
Industrial group
Buying and selling of own real estate